FRA-1 TARGET GENES AS DRUG TARGETS FOR TREATING CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 6, 2012
app pub date -
Mar 16, 2012
filing date -
Sep 16, 2009
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to the use of an inhibitor of one of the following polypeptides, wherein the polypeptide is represented by the following sequences selected from the following group SEQ ID NO:1-32, each of the polypeptide being preferably as identified in claim 1 as a medicament, preferably for preventing, delaying and/or treating metastasis in a cancer patient. The invention also relates to a diagnostic portfolio comprising or consisting of isolated nucleic acid sequences, their complement or portions thereof, of a combination of genes selected from the groups consisting of genes represented by the following sequences SEQ ID NO:1-32 or SEQ ID NO:1-169.
First Claim
Family
International Classification(s)
- A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
- C07H:SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTI....
- C12Q:MEASURING OR TESTING PROCESSES INVOLVING ENZYMES O....
- A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....
- C40B:COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL ....
- C07K:PEPTIDES
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully